Diabetes - European Medical Journal

This site is intended for healthcare professionals

Continue

Diabetes

Filter
2 Mins
10 Nov 2020

Offspring of Mothers with Gestational Diabetes: A 5-Year Follow-Up

Females with gestational diabetes mellitus (GDM) are at an increased risk of complication during delivery (adverse perinatal outcomes) and having abnormalities in glucose metabolism postpartum…
2 Mins
10 Nov 2020

Diabetic Kidney Disease Phenotypes, Mortality, and Incidence of Vascular Outcomes in a Single-Centre Cohort with Type 2 Diabetes: A 13-year Follow-up Observational Study

Diabetes is an emerging public health problem because of the high mortality and morbidity rates associated with its serious complications…
1 Mins
10 Nov 2020

Macrophage Phenotype in Diabetic Wound Healing

Diabetic foot ulcers (DFU) are usually chronic wounds that present in the inflammatory phase of the wound healing process…
1 Mins
5 Nov 2019

Perceptions of Life with Diabetes Revealed through a Solution-Focussed Brief Therapy Exercise via Twitter

The ‘Miracle Question’ (MQ) is a questioning tool used in a solution-focussed approach to care. The goal is to help individuals envision a desired future…
2 Mins
5 Nov 2019

Trends in the Incidence of Prediabetes Among Younger and Older Immigrants in Canada, 2011–2017

The burden of prediabetes appears to be increasing worldwide. According to the International Diabetes Federation (IDF), low and middle-income countries…
2 Mins
5 Nov 2019

Once-Weekly Semaglutide versus Daily Canagliflozin in Type 2 Diabetes Mellitus (SUSTAIN 8): How Do They Compare?

Both glucagon-like peptide-1 receptor agonists (GLP-1RA) and sodium–glucose cotransporter-2 inhibitors (SGLT-2i) are effective and well-tolerated…
2 Mins
5 Nov 2019

SUSTAIN 10: Efficacy and Safety of Semaglutide 1.0 mg Once Weekly versus Liraglutide 1.2 mg Once Daily

Subcutaneous semaglutide once weekly (OW) and subcutaneous liraglutide once daily (OD) are two glucagon-like peptide-1 receptor agonists (GLP-1RA)…
2 Mins
5 Nov 2019

Deep Serum Proteomics Reveal Biomarkers and Causal Candidates for Type 2 Diabetes Mellitus

The prevalence of Type 2 diabetes mellitus  (T2DM) is expected to increase rapidly in the next decades, posing a major challenge to societies worldwide.
We’ve noticed you’re accessing
from North/South America.